Assessment of Wearable Sensors During Experimental Human Influenza Infection (Sigma Plus)

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 11, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

May 17, 2021

Conditions
Influenza A H3N2
Interventions
DEVICE

Lumee Oxygen Platform

Two sensors will be inserted (one in the skin fo the upper arm and one on the side of the chest). A wireless patch reader is placed on top of the skin over the area where the sensor has been placed to measure local oxygen content.

Trial Locations (1)

W2 1PG

Imperial Clinical Research Facility, Imperial College London, London

Sponsors

Collaborators (1)

All Listed Sponsors
lead

Imperial College London

OTHER

collaborator

Duke University

OTHER

collaborator

RTI International

OTHER

collaborator

Defense Advanced Research Projects Agency

FED

NCT04204993 - Assessment of Wearable Sensors During Experimental Human Influenza Infection (Sigma Plus) | Biotech Hunter | Biotech Hunter